Dolutegravir Compared to Darunavir/Ritonavir , Each in Combination With Dual Nucleoside Reverse Transcriptase Inhibitors (NRTIs) in ART-naive Subjects
Conditions
- Infection, Human Immunodeficiency Virus
Interventions
- DRUG: dolutegravir 50 mg OAD
- DRUG: darunavir 800mg OAD
- DRUG: ritonavir 100mg OAD
Sponsor
ViiV Healthcare
Collaborators